Adverse cutaneous reactions to parenteral administration of proteins (Q102274): Difference between revisions

← Older edit

@@ Property / Canonical URI @@
+https://id.who.int/icd/entity/888724880
@@ Property / Canonical URI: https://id.who.int/icd/entity/888724880 / rank @@
+Normal rank
@@ Property / CURIE @@
+CID11:ID_888724880
@@ Property / CURIE: CID11:ID_888724880 / rank @@
+Normal rank
@@ Property / Canary Token @@
+dki-india-ID_888724880
@@ Property / Canary Token: dki-india-ID_888724880 / rank @@
+Normal rank
@@ Property / Verification Status @@
+Concluído
@@ Property / Verification Status: Concluído / rank @@
+Normal rank
@@ Property / Knowledge Architect @@
+https://pauloleads.com.br/cases-publicos/
+Normal rank
@@ Property / Collection date @@
+August 2026Timestamp +2026-08-15T00:00:00Z
Timezone +00:00
Calendar Gregorian
Precision 1 day
Before 0
After 0
-Timestamp
++2026-08-15T00:00:00Z
-Timezone
++00:00
-Calendar
+Gregorian
-Precision
+day
 Before
 After
@@ Property / Collection date: 15 August 2026 / rank @@
+Normal rank

Latest revision as of 19:12, 16 August 2026

Undesired effects with cutaneous manifestations resulting from parenteral administration of proteins. These include vasculitis, serum sickness reaction and anaphylaxis.

Language	Label	Description	Also known as
default for all languages	ID_888724880
English	Adverse cutaneous reactions to parenteral administration of proteins	Undesired effects with cutaneous manifestations resulting from parenteral administration of proteins. These include vasculitis, serum sickness reaction and anaphylaxis.